Insights

Market Need VivaQuant specializes in ECG quantitative analysis and noise reduction, addressing a critical need in biomedical and drug safety research for accurate arrhythmia measurement from ambulatory ECGs. This positions them well for sales targeting pharmaceutical companies, CROs, and academic research labs focused on cardiac safety.

Proprietary Tech MDSP technology that eliminates 95% of noise while preserving fidelity highlights a competitive edge in data quality and reliability, offering a compelling value proposition for customers requiring high-sensitivity measurements and robust signal processing in challenging data conditions.

Product Lifecycle A history of sequential product launches (AE-1010 Rhythm Express, RX-1 mini) and ongoing enhancements indicates a mature product roadmap with opportunities for upsell to existing customers and cross-sell across different ECG analysis modules and services.

Expansion Potential With a human scale of 11-50 employees and revenue in the mid-range, VivaQuant can scale through partnerships with larger CROs or pharmaceutical firms seeking specialized ECG analysis capability, including integration with cloud/CDN and analytics platforms used by potential clients.

Competitive Positioning Recent recognition as a Tekne Awards finalist and patent activity around physiological signal denoising provide credibility for sales pitches, enabling conversations around differentiated IP, regulatory-ready capabilities, and long-term collaboration opportunities.

Similar companies to VivaQuant

VivaQuant Tech Stack

VivaQuant uses 4 technology products and services including Cloudflare CDN, Cloudflare, YouTube, and more. Explore VivaQuant's tech stack below.

  • Cloudflare CDN
    Content Delivery Network
  • Cloudflare
    Content Management System
  • YouTube
    Video Players
  • Google Analytics
    Web Analytics

Media & News

VivaQuant's Email Address Formats

VivaQuant uses at least 1 email format:
VivaQuant Email FormatsExamplePercentage
FLast@vivaquant.comJDoe@vivaquant.com
100%

Frequently Asked Questions

What is VivaQuant's phone number?

Minus sign iconPlus sign icon
You can contact VivaQuant's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is VivaQuant's official website and social media links?

Minus sign iconPlus sign icon
VivaQuant's official website is vivaquant.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does VivaQuant generate?

Minus sign iconPlus sign icon
As of October 2026, VivaQuant's annual revenue is estimated to be $10M - $25M.

What is VivaQuant's NAICS code?

Minus sign iconPlus sign icon
VivaQuant's NAICS code is 5112 - Software Publishers.

How many employees does VivaQuant have currently?

Minus sign iconPlus sign icon
As of October 2026, VivaQuant has approximately 23 employees across 2 continents, including North America and Europe. Key team members include Machine Learning Engineer: D. S. Explore VivaQuant's employee directory with LeadIQ.

What industry does VivaQuant belong to?

Minus sign iconPlus sign icon
VivaQuant operates in the Software Development industry.

What technology does VivaQuant use?

Minus sign iconPlus sign icon
VivaQuant's tech stack includes Cloudflare CDN, Cloudflare, YouTube and Google Analytics.

What is VivaQuant's email format?

Minus sign iconPlus sign icon
VivaQuant's email format typically follows the pattern of FLast@vivaquant.com. Find more VivaQuant email formats with LeadIQ.

How much funding has VivaQuant raised to date?

Minus sign iconPlus sign icon
As of October 2026, VivaQuant has raised $295K in funding. The last funding round occurred on Dec 31, 2019 for $120K.

When was VivaQuant founded?

Minus sign iconPlus sign icon
VivaQuant was founded in 2009.
VivaQuant logo

VivaQuant

Software DevelopmentMinnesota, United States11-50 Employees

VivaQuant develops software tools for quantitative ECG analysis used in biomedical and drug-safety research, and it also operates a services group that provides end-to-end evaluation of arrhythmia risk and quantification of cardiac intervals. The offering centers on MDSP technology, which eliminates 95% of noise while preserving fidelity, enabling precise measurements from continuous ambulatory ECG data where artifact and signal degradation are common. 

The company primarily serves researchers and product teams in pharmaceutical and biomedical fields seeking objective assessments of arrhythmia liability. By reducing noise and artifacts in ambulatory ECGs, VivaQuant’s software and services support more sensitive and accurate analyses. Based in St. Paul, Minnesota, the firm is a small to mid-sized software development operation. In 2021, VivaQuant was named a finalist for the Tekne Awards.

Section iconCompany Overview

Phone number
NAICS Code
5112 - Software Publishers
Founded
2009
Employees
11-50

Section iconFunding & Financials

  • $295K

    VivaQuant has raised a total of $295K of funding over 2 rounds. Their latest funding round was raised on Dec 31, 2019 in the amount of $120K as an Angel.

  • $10M - $25M

    VivaQuant's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.